MxP® Quant 1000 kit

New unboxing and demonstration videos

Discover our new video playlist for the biocrates MxP® Quant 1000 kit. Watch the unboxing to get a first look at all components included in the MxP® Quant 1000 kit, and follow along with step by step demonstrations of the PITC, NPH, and lipid preparation workflows. All videos are intended for demonstration purposes only. For complete and detailed instructions, please refer to the respective kit user manual.

Metabolite of the month

Fructose

In this section, our scientists focus on a specific metabolite each month, discussing its function and implications for research and health. This month’s article explores fructose, a sweet molecule with systemic impact.

Scientific posters

Explore our brand-new biocrates poster gallery

If you missed our poster presentations at recent conferences or want to take an in depth look at specific posters, you can now access them in our brand new poster gallery. Explore how our kits are used across multiple matrices and MS platforms.

Longitudinal monitoring of metabolomic profiles with at-home dried blood sampling devices

Application note

Our latest application note shows how minimally invasive longitudinal sampling reveals both day to day fluctuations as well as long term metabolic trends that are highly relevant for health monitoring. With newly established matrix specific reference ranges for dried blood and standardized quantitative measurements using biocrates kits, the study demonstrates how longitudinal metabolomics can help identify early deviations from an individual’s normal levels and provide a clearer, more reliable picture of metabolic health over time.

How metabolomics is improving healthcare

6 must-read studies from 2025

After decades of development, metabolomics is on the cusp of integration into medical practice. For over 20 years, biocrates has focused on enabling this transition through robust, transferable, and scalable technology. In this article, we highlight six selected studies published in 2025 by biocrates’ community of users, that span multiple regions, therapeutic areas, and dimensions of the future implementation of metabolomics in medicine and drug development.

Proteomics discoveries that made an impact

2025 in review

Our partner PreOmics highlights a selection of publications from 2025 that showcase the power of proteomics driven discovery. These studies demonstrate how advanced sample preparation technologies enable deeper proteome profiling across complex biological matrices such as plasma, cerebrospinal fluid, and serum. Supported by robust and scalable workflows for clinical and translational research, the publications illustrate how PreOmics solutions deliver reproducible depth, sensitivity, and confidence for uncovering disease mechanisms.

Unlocking biological insight with Biognosys software

A 2025 publication overview

Our partner Biognosys highlights selected publications from 2025 that showcase the power of proteomics for understanding biology. Researchers relied on Spectronaut® and SpectroDive™ to deliver deep, quantitative and reproducible insights across diverse applications including biomarker discovery, multiomics integration and chemoproteomic target identification. These studies demonstrate how the Biognosys software ecosystem transforms complex proteomics data into confident biological discovery.

2025 at biocrates

A year shaped by 5P medicine

In our latest blog retrospective, we look back on how the 5P medicine framework shaped our view of metabolomics in 2025. From dedicated blog series to events and our podcast, we grew our common understanding of the place of metabolomics in all spheres of the life sciences. This article traces the red thread joining our efforts to make metabolomics accessible to the heart of the scientific community that beats for the reliable tools that will drive the transformation of medicine with omics.

Recap | The Metabolomist season IV

Remarkable voices and inspiring perspectives

As the year comes to an end, we look back on another inspiring season of The Metabolomist. In 2025, we explored the secret stories of metabolomics in connection with all 5Ps.
Host Alice Limonciel explored the challenges, the breakthroughs, and the ideas shaping the future of research and health with metabolomics, multiomics, exposomics and how they are transforming medicine.

Brand-new knowledge base

Guidance for every step of your kit workflow

Meet your shortcut to a smooth journey through every step of the kit workflow. The biocrates knowledge base brings together step-by-step guides, proven best practices, and expert insights – so you can get set up faster, troubleshoot with confidence, and get results you can trust. Plus, our new tool gets you support even quicker when you need it.

Metabolic phenotyping services

Expert support from study design to actionable results

Keep your studies moving with biocrates’ metabolic phenotyping – ISO-certified, quality-controlled analytics across the metabolic spectrum. Choose from 12 targeted assays quantifying over 1,500 metabolites. We support you end-to-end – sampling and shipment, project management, data analysis/biostatistics, and expert interpretation with pathway visuals.

biocrates expands cross-platform compatibility

MxP® Quant 1000 kit now validated for Bruker EVOQ® DART-TQ⁺

We’re proud to announce that the MxP® Quant 1000, our most comprehensive kit, is now optimized and validated on the Bruker EVOQ® DART-TQ⁺ mass spectrometer (RUO). This marks a milestone – the first biocrates standardized kit for broad quantitative metabolomics on a Bruker triple quadrupole platform.
Covering 1,233 metabolites across 49 biochemical classes, the MxP® Quant 1000 kit enables robust, reproducible quantification across diverse sample matrices. Researchers can now benefit from the same standardized workflow across Bruker and other major mass spectrometer platforms, continuing biocrates’ long-lasting vendor neutrality and cross-platform reproducibility.

Energy metabolism in cancer

Mechanisms, plasticity, and applications

Cancer cells reprogram energy metabolism to fuel rapid growth, often relying heavily on glycolysis and glutaminolysis. Lactate and other oncometabolites generated in the TCA cycle drive proliferation and immune evasion. Metabolomics helps uncover these processes. With biocrates’ kits, key metabolites can be quantified and biomarkers like the pyruvate-to-lactate ratio investigated, offering insights into tumor biology and potential therapies.

Using biocrates’ MxP® Quant 1000 kit across MS platforms

Technical note

Our latest technical note confirms the reproducibility and robustness of the MxP® Quant 1000 kit across various MS platforms and labs. High correlation and broad coverage were observed on all instruments. Paired with the AI-powered WebIDQ workflow manager, this solution streamlines data processing and ensures consistent, high-quality results, regardless of the MS system used.

biocrates becomes part of Bruker Corporation

A new chapter in quantitative metabolomics

We are excited to share that biocrates life sciences gmbh has joined Bruker Corporation, marking a major milestone in the evolution of quantitative metabolomics. As a global leader in mass spectrometry-based metabolite and lipid profiling, biocrates will continue to drive innovation and accessibility in multiomics – now with the expanded support and reach of Bruker. This partnership strengthens our shared mission to deliver reproducible, standardized solutions for precision research worldwide.